Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 August 2023 | Story Lunga Luthuli | Photo Francois van Vuuren
Bloemfontein Campus Solar Farm
The solar plant on the UFS’s Bloemfontein Campus, part of the university’s commitment to combatting loadshedding and embracing sustainable energy.

The University of the Free State (UFS) has installed solar plants across its three campuses.

The university says this is in response to the call for urgent solutions to loadshedding and the promotion of environmentally sustainable, cleaner, and renewable energy solutions.

Nicolaas Esterhuysen, Director of Engineering Services at UFS University Estates, said,

“The PV (photovoltaic) systems are grid-tied without storage to ensure maximum benefits and faster payback periods.”

Esterhuysen said the UFS has saved up to R32,5 million since the first solar plant was commissioned in 2017 to help the UFS reduce the impact of loadshedding and its carbon footprint and energy costs. “This will substantially increase this year with the commissioning of two large new ground-mounted solar plants on the Bloemfontein Campus,” he said.

“The microgrid installation on Qwaqwa Campus is one of the biggest solar diesel hybrid systems installed in South Africa. It allows us to keep the campus running despite excessive power interruptions.”

The UFS is currently embarking on research as part of the Grid-related Research Group (GRRP) under the Interdisciplinary Centre for Digital Futures (ICDF) to also help staff and students with understanding renewable energy and sustainability.

Esterhuysen said the plants are further evidence of the UFS’s commitment to renewable and energy saving solutions. “It is our flagship project, but our focus is also on energy saving initiatives – to ensure we are becoming more energy efficient and eliminate energy wastage. We have plans for expansion on all campuses. Some of the highlights are an off-grid solution for the new student centre at Qwaqwa Campus and to make South Campus a self-sustaining campus.”

The installed grid-tied system solar plants are operating without batteries on all three campuses, giving the university an optimal configuration between capital cost and payback period.


The energy generated at the solar plants:

Bloemfontein Campus – 3688 kWp

Qwaqwa Campus – 918 kWp

South Campus – 759 kWp

Paradys – 125 kWp

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept